Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | +69.64% | −5.40% | −4.26% | −5.29% | +43.75% | +87.49% | +96.05% | +809.29% | +247.27% | +259.78% |
| ES-GENOME | +64.37% | −2.58% | +0.99% | −7.42% | +25.05% | +60.84% | +56.72% | +64.10% | −46.29% | −47.32% |
| SCBGENOME(A) | +68.85% | −3.07% | +1.31% | −6.33% | +25.51% | +60.04% | +61.33% | +78.78% | −45.52% | −46.82% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes NTRA: money market or bond funds, or no holdings data yet
| ES-GENOME | SCBGENOME(A) | |
|---|---|---|
| Held by both | ||
 Twist Bioscience | 10.83% | 10.03% |
 10x Genomics | 10.50% | 8.02% |
 Tempus AI Inc Class A common… | 9.36% | 7.15% |
 CRISPR Therapeutics | 5.49% | 4.20% |
 Absci | 5.30% | 4.05% |
| Personalis | 5.12% | 3.91% |
 Guardant Health | 4.83% | 3.69% |
 Natera | 4.75% | 3.63% |
 Illumina | 4.71% | 3.60% |
 CareDx | 4.55% | 3.48% |
30 Dec 2025 → 3 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBGENOME(A) | +68.85% | 42.54% | 1.62 |
| ES-GENOME | +64.37% | 42.32% | 1.52 |
| NTRA | +69.64% | 52.59% | 1.32 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | NTRA | ES-GENOME | SCBGENOME(A) |
|---|---|---|---|
Fund details | |||
| Fund size | N/A | 225 million | 261 million |
| Inception date | N/A | 23 Mar 2021 | 20 Aug 2021 |
| Master fund | N/A | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution UCITS, ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | กองทุน ARK Genomic Revolution ETF |
| Dividend policy | N/A | Does not pay | Does not pay |
Risk and currency hedging | |||
| Risk level | N/A | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 79.06% | 57.68% |
Minimum purchase and redemption | |||
| First purchase | N/A | 1 THB | 1,000 THB |
| Subsequent purchase | N/A | 1 THB | 1,000 THB |
| Redemption (amount) | N/A | 1 THB | 1,000 THB |
| Redemption (units) | N/A | 1 units | No minimum |
| Balance (amount) | N/A | No minimum | 1,000 THB |
| Balance (units) | N/A | No minimum | No minimum |
Order cut-off and redemption payment | |||
| Buy before | N/A | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+4 |
